Role of Unani drugs (Tiryaqe Wabai, Arque-e-Ajeeb, Habb-e- Loban) in the treatment of COVID-19 patients.
Phase 2
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/01/030825
- Lead Sponsor
- Ministry of AYUSH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
American Society of Anesthesiologists (ASA) class I &II.
Confirmed COVID-19 case (RT-PCR for SARS-CoV-2 positive).
Exclusion Criteria
Patient not consenting.
Suspected COVID patient.
American Society of Anesthesiologists (ASA) class III, IV & V.
Pregnant and lactating women.
History of Hypersensitivity/non-responsive to the study drug or any of its ingredients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method